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Digital technology, which includes the collection, analysis, and use of data from a variety of digital devices, has the potential to
reduce the prevalence of disorders and improve mental health in populations. Among the many advantages of digital technology
is that it allows preventive and clinical interventions, both of which are needed to reduce the prevalence of mental health disorders,
to be feasibly integrated into health care and community delivery systems and delivered at scale. However, the use of digital
technology also presents several challenges, including how systems can manage and implement interventions in a rapidly changing
digital environment and handle critical issues that affect population-wide outcomes, including reaching the targeted population,
obtaining meaningful levels of uptake and use of interventions, and achieving significant outcomes. We describe a possible
solution, which is to have an outcome optimization team that focuses on the dynamic use of data to adapt interventions for
populations, while at the same time, addressing the complex relationships among reach, uptake, use, and outcome. We use the
example of eating disorders in young people to illustrate how this solution could be implemented at scale. We also discuss system,
practitioner-related, and other issues related to the adaptation of such an approach. Digital technology has great potential for
facilitating the reduction of mental illness rates in populations. However, achieving this goal will require the implementation of
new approaches. As a solution, we argue for the need to create outcome optimization teams, tasked with integrating data from
various sources and using advanced data analytics and new designs to develop interventions/strategies to increase reach, uptake,
use/engagement, and outcomes for both preventive and treatment interventions.
(J Med Internet Res 2020;22(7):e17493) doi: 10.2196/17493
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Introduction
Digital technology, which includes the collection, analysis, and
use of data from a variety of digital devices and other sources,
has the potential to reduce the prevalence of mental health
disorders and improve mental health in populations by
integrating preventive interventions to reduce incidence with
clinical interventions to reduce existing cases, both of which
are needed to reduce the prevalence of mental health disorders,
into health care and community delivery systems. Furthermore,
digital technology has the advantage of collecting large amounts
of information that can inform preventive and intervention
processes. Such data need to be analyzed and, even more
importantly, used to adapt and improve a variety of
interventions, including digital ones, toward optimizing
outcomes. The process of optimizing outcomes needs to be
dynamic and responsive to the rapid changes in the use of digital
technology, consumer interests and preferences, and regulations
among other factors as well as to enable rapid changes in the
content and process of intervention delivery (a study by Michie
et al [1] provides an excellent overview of challenges in
developing and evaluating digital interventions targeting
behavior change as well as methods for doing so). At the same
time, interventions need to be designed in partnership with
stakeholders and consumers to increase the likelihood of
subsequent implementation and dissemination [2-6].
The need to find novel solutions for improving mental health
outcomes in populations is based on extensive data, showing
that mental health disorders are very common and severely
undertreated. In the United States, for instance, approximately
25% of the population experiences a mental health disorder
during a given year and 50% in their lifetimes [7]; however,
fewer than 30% of individuals with mental health disorders
receive any treatment [8,9]. Thus, solutions for reducing
prevalence in populations will require approaches that can be
applied on a large scale [10].
To meet the need for outcome optimization at a population level,
new approaches are required. Digital interventions have been
developed to increase access and reduce costs, but engagement
with these interventions is suboptimal, with many individuals
engaging in only 1 or 2 sessions and fewer than half completing
more than half of the treatment [11]. A recent study, for instance,
of 93 mental health apps found that the medians of app 15-day
and 30-day retention rates were 3.9% (IQR 10.3%) and 3.3%
(IQR 6.2%), respectively [12]. To improve population-level
outcomes, we have recently argued for the need for outcome
optimization at the population level—an approach that
simultaneously attempts to improve reach, uptake, engagement,
and outcomes [1,13,14]. In this paper, we discuss how
prevalence reduction in whole populations might be achieved
through outcome optimization applied to both preventive and
clinical interventions and suggest ways to address potential
issues raised by this approach. Of note, outcome optimization
applies to the entire population rather than the individual, and
as we are focusing on prevalence, a reduction in caseness.
However, as discussed later, the approach applies as well to any
mental health or behavioral outcomes. We will argue that
outcome optimization needs to be directed by a group of
individuals with a diverse set of skills, which we refer to as an
outcome optimization team, tasked with both reducing
prevalence and incidence of a disorder in a population. Such
teams would integrate data from various sources to increase
reach, uptake, use/engagement, and outcomes for both
preventive and clinical interventions and consider
interactions/trade-offs among the variables. In a population
model, focusing on incremental improvements in effect size
may have much less impact on prevalence than focusing on
increasing reach. For instance, Moessner and Bauer [15] noted
that an increase of 10% from 10% in treatment utilization would
decrease the number of cases by an additional 5%, whereas an
improvement in treatment efficacy of 10% (from 10%) would
only reduce the number of cases by approximately 2%.
However, if the intervention used is not effective whatsoever
or of very limited effectiveness, there would not be any
population health benefits, irrespective of reach, uptake, and
use, and there may also be harm associated with the intervention.
Therefore, when considering how to optimize an intervention
effect on a population, the aim should be to focus on reach while
also considering how to improve efficacy.
The Overall Approach
Prevalence Reduction
The prevalence of a disorder in a population is measured by
two primary factors: the number of individuals who are
identified with the disorder and the number of individuals who
develop the disorder during a defined period. To reduce
prevalence, there are two necessary components: preventive
interventions that reduce disorder onset (the incidence of new
cases) and clinical interventions that are effective enough so
that the individual already affected with the disorder no longer
meets the clinical criteria for that condition.
A core premise of the approach we are suggesting is the
recognition that interventions evaluated under carefully
controlled circumstances in selected, often convenience
populations may not be as feasible or effective when applied
more broadly [5,16,17]. Therefore, to reduce the burden of
mental health disorders in populations by delivering
interventions at scale, interventions need to be carefully and
systematically adapted to the needs, requirements, and interests
of different defined populations in a dynamic way. In the
following sections, we discuss the necessary components to
achieve prevalence reduction through an outcome optimization
model and use the example of eating disorders in young people
to illustrate what we are proposing. The general model we follow
is described in detail in a paper by Wilfley et al [18]. In this
model, individuals in various populations are identified via an
evidence-based screening [19] that sorts respondents into the
following categories: possible anorexia, possible other eating
disorder, risk of an eating disorder, and low risk of an eating
disorder. The screening tool then provides appropriate
prevention or treatment recommendations.
Outcome Optimization Teams
Affecting the key variables for optimizing outcomes is both a
management and scientific process. As already mentioned, we
have previously described the need for organizations to create
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outcome optimization teams or similar groups, tasked with
monitoring the key variables mentioned in Figure 1 and
developing and implementing strategies to improve the various
targets and key outcomes. These teams must possess a set of
specific skills to enable effective use of the data to improve the
key outcomes, use novel trial designs to conduct rapid
evaluations, and iteratively adapt available interventions to
improve the effects of the interventions on all critical variables
(ie, from reach to outcome). The outcome optimization team
needs to include individuals who are able to address
administrative issues, manage complex problems, design social
media and intervention strategies, and analyze and interpret
data, as well technology partners and oversight members
(including consumers), brought together with adequate resources
for the task. There are now many examples of applications of
technology (eg, e-commerce) in areas not related to health and
companies that now employ the equivalent of outcome
optimization teams to one extent or another, with diverse skills
and competencies, focusing on data science to help optimize
the outcomes of interest. These approaches are equally relevant
to population-level mental health interventions.
Figure 1. Outcome optimization model enabling elements, activities, and targets.
Outcome Optimization Targets
In the optimization outcome approach, the primary components
subject to intervention and evaluation (any of which could be
targeted separately) are (1) prevalence of the disorder, the
number of individuals in the population who are appropriate
for a clinical intervention; (2) risk for the disorder, the number
of individuals in the population who are appropriate for a
preventive intervention (thus reducing incidence); (3) reach,
the number of individuals in a population who are offered a
relevant prevention or clinical intervention; and (4) outcome,
the number of individuals who begin a program and achieve
the desired outcome within a set time frame. The
individual-level outcome would be categorical (case/no case),
and the population-level outcome would be prevalence (defined
as new cases and existing cases). In addition, two other variables
are important for optimizing individual- and population-level
outcomes: (5) uptake, how many of those individuals offered
an intervention actually begin it (eg, create a user account for
a web-based, guided self-help program and see a therapist); and
(6) engagement/use (eg, how much of the intervention is used).
To improve overall outcomes, we will argue that each of these
parameters can be targeted individually and, yet, should be
targeted and measured simultaneously, given that changes in
one variable can have a downstream impact on another variable.
For example, increased reach can reduce uptake rates, as less
motivated individuals may be screened/included, or delivery of
more effective treatments characterized by greater demands on
client participation might be associated with reduced
engagement.
We illustrate the different elements of our proposed approach
by drawing from our research with eating disorders. Eating
disorders are common and disabling problems with the highest
mortality rates of any psychiatric illness. The risk factors for
eating disorders are well known and have been shown to reduce
incidence when addressed [20], and a variety of effective and
cost-effective clinical interventions are available [21-23].
Furthermore, we have already developed and implemented an
evidence-based screening on the web to categorize college
students as being at risk for or with an eating disorder. Following
completion of the web-based screening completion, we have
provided appropriate and effective digital interventions or
referrals to in-person intervention when appropriate at scale
[24].
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Reach
In this paper, reach represents the percentage of the population
who are at risk for or who have a clinical disorder who complete
a web-based screening and who are offered a preventive or
clinical intervention appropriate to their needs and interests.
We focus on reach via a web-based screening, but individuals
at risk for or with clinical disorders could also be identified in
other ways, including clinical interviews, algorithms, and, of
course, through self-identification.
In the example of eating disorders, the goal of a prevalence
reduction program should be to reach most individuals at risk
for or with eating disorders. The prevalence of eating disorders
in female college students has been estimated to be
approximately 13.5% [25]; the rates for those at risk of eating
disorders are even higher. For instance, Lipson et al [26] found
that approximately 17.29% (1163/6723) of women in their
survey had high weight and shape concerns, and many others
had binge eating and/or weight and shape concerns without
meeting clinical criteria. Conservatively, at least 25% of
college-aged women are at risk for but do not have eating
disorders. Unfortunately, reach in most populations is often
very low. For instance, in our recent study, which used screening
in college and universities to recruit women to use an eating
disorder intervention, 1.42% (4284/300,613) of undergraduate
women completed the web-based screening [27]. Thus,
increasing reach is a high priority. An outcome optimization
team might use three strategies to increase reach in the
population. Hypothetically, the initial focus might be to provide
screening through customary channels (eg, student listservs and
flyers). In this model, approximately 5.00% (50/1000) of those
with eating disorders completed the screening. To increase
reach, the next optimization strategy might be to add the use of
targeted Facebook advertisements, followed by using both
targeted Facebook and Google advertisements. In the example,
we assumed that adding Facebook advertisements increased the
reach to 7.50% (75/1000), and by adding Google advertisements
(strategy 3), the reach increased to 10.00% (100/1000). We
realize that these examples are hypothetical, but there is very
sparse literature on the use of different digital techniques (eg,
social marketing) for increasing reach in targeted populations.
Ten percent is still far below the goal of reaching most of the
population, and targeted Facebook and Google advertisements
can be expensive. Other, perhaps more effective and less
expensive approaches could be used. For instance, web-based
screening for an entire student population for a variety of
problems, including eating disorders, could be routinely
required, or a web-based screening sent directly to individual
student emails could be offered. The Healthy Minds Network
routinely reaches approximately 16% of students using the latter
approach [28]. The outcome optimization team should
continuously experiment with new approaches for increasing
overall reach and reach for subpopulations of interest.
Uptake
Once individuals have completed screening and have been
offered feedback that directs them to a tailored intervention, the
next critical variable is the uptake of the intervention, defined
as having at least begun an intervention, such as engaging with
at least some of a digital intervention or attending at least one
individual or group therapy session. The uptake of interventions
can be quite low. However, in our recent study of college
women, 75.5% (690/914) of female students who were eligible
for the clinical trial agreed to be randomized; of those
randomized to the intervention, 79.2% (305/385) began it [27].
Data from another study that provides prevention and clinical
interventions to students in public universities in the state of
Missouri found that uptake rates of the digital programs offered
for both the high-risk population and clinical population were
about 44.2% (420/955) and 49.3% (187/379), respectively [24].
In another study, 26% (16/61) of students with possible anorexia
nervosa who were recommended to seek treatment reported
doing so at follow-up [29], and Lipson et al [26] found that
18.0% (345/1916) of students at risk of an eating disorder
referred to an indicated preventive program began it. Overall,
available data on the uptake of interventions have varied quite
widely and may be impacted by such features as the population
screened and the accessibility and perceived helpfulness of the
interventions offered.
In our example, we assumed that for the clinical population,
50% of individuals provided with a referral recommendation
will at least go on the web once, see a provider, or in some other
way, engage in an intervention. A strategy that lends itself to
digital technology is to provide a set of interventions that can
be adapted to different needs and interests, with different
resources to subpopulations within the larger targeted
population. In our hypothetical example, the outcome
optimization team found that the baseline uptake rate (number
of individuals who were offered an intervention who began it)
was 50%. The outcome optimization team explored and enacted
a number of options to increase uptake. First, 25% of the sample
was eligible but expressed little intention of acting on the
recommendation and was provided a brief motivational
intervention. Second, approximately 5% of the sample was
found to favor Spanish as a primary language. A Spanish
language version was authored and offered to interested
individuals. A consumer survey found that approximately 25%
of the reached population would choose in-person therapy but
reported not being able to afford it. As a way to address this
issue, the outcome optimization team created an option where
therapists trained in evidence-based treatments for eating
disorder (eg, cognitive behavioral therapy–guided self-help)
would be reimbursed for treating individuals sponsored by a
nonprofit organization, and this was offered, randomly, to half
the individuals who might want to it. Another issue revealed
by the outcome optimization team through consumer needs
assessments was that many individuals with eating disorders
live in areas with no available treatment expertise for eating
disorders and/or preferred teletherapy to face-to-face therapy.
The outcome optimization team, thus, developed a teletherapy
eating disorder program based on previous work. To increase
motivation in future users who met the characteristics identified
through a moderator analysis, a postscreen feedback message
was then designed to inform them that previous users with
characteristics similar to theirs had achieved positive outcomes
as a result of the program. Of course, the issues affecting uptake
are not mutually exclusive, and variables such as cost, language,
and expectation of success may have different impacts on
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different individuals depending on their needs and interests. All
subpopulations are part of the larger population, and the needs
and relative importance of subpopulations will continue to
change, reflecting, for instance, changing demographics in the
targeted population. Uptake will also change depending on
consumer needs and interests, available resources, cost, and
other factors.
One of the challenges of population-based interventions is that
little is actually known about what users may want. A general
strategy is to first consider the interests/resources of the
users/stakeholders, followed by using user-centered design [30]
approaches to build out interventions designed with ultimate
implementation in mind [5]. In building out the interventions,
modern designs would be used (eg, the multiphase optimization
strategy and others [1,2,31,32] to engineer optimized
interventions, before evaluation in randomized controlled trials).
Depending on the size of the targeted population, other general
approaches could be examined in subsamples. For instance,
futility studies of stepped-care approaches, which might appeal
to organizations as a way of reducing costs, could be examined
[18,33].
Use/Engagement
Program use, often defined as engagement, is the next key
variable to consider. Use includes several factors, such as the
amount of the prescribed intervention used (eg, sessions of
therapy attended and web-based sessions opened); application
of the skills outside of the program; and/or sufficient use to lead
to reductions in clinical targets, clinical status, risk factor
reduction, or other indicators of significant improvement [11].
For example, the results might indicate that individuals who
complete a specific amount of intervention might show clinically
significant improvements. This amount might refer to the
number of sessions attended in face-to-face therapy or pages
opened in web-based interventions. Important to determining
sufficient engagement is to examine progression within an
intervention both for symptom improvement and successful
adaptation of behaviors, skills, and other targets considered
necessary for a meaningful outcome. Digital technology and
analytic methods offer the potential to passively assess a number
of variables that might affect engagement and outcome (eg,
activity, sleep, and search history). This offers advantages over
other types of intervention in the availability of extensive data
related to program use and, therefore, easier determination of
use cutoffs.
Perhaps the most important use problem is that of early dropout.
Early dropout has been defined in various ways, but it is defined,
for the purpose of this discussion, as individuals who begin an
intervention but complete an insufficient amount of a program
to have a positive outcome (however, even this definition is
problematic as many individuals seem to benefit from simply
beginning an intervention or using it for only a short time) [1].
Recent meta-analyses of web-based studies report high rates of
early dropout, partly depending on the amount of support offered
[34]. Individuals may drop out of an intervention for a variety
of reasons. A major goal of the outcome optimization team
would be to understand why people are dropping out
(particularly before they achieve a meaningful outcome) and to
enact strategies to reduce dropout rates. Furthermore, the
outcome optimization team would monitor use/dropout rates as
they relate to clinical or preventive outcomes to help determine
when a problem exists.
As with other components of the intervention, strategies to
reduce early dropout and increase rates of sufficient engagement
could be developed and tested. For instance, in a substudy of
our recently completed trial [12], we examined the relationship
between early and later session completion (n=47): individuals
who completed at least three sessions were likely to complete
at least 50% of the total program. In another analysis, we found
that a very high score on a measure of thin body ideal (TBI)
internalization predicted students likely to drop out of the
intervention early. We then examined the components of the
first three sessions to see what might have negatively impacted
21 individuals with a high TBI. One component tasked users
to write a letter to their body. Of these 21 individuals, 10 rated
it as not useful at all, 10 as somewhat useful, and only one as
very useful. Therefore, we dropped this technique from the
program and added a motivational interviewing piece. A
subsequent sample of the first 59 users of the motivational
interviewing piece was reviewed. The component was rated as
not helpful by 10% (6/10) of individuals, a bit helpful by 44%
(26/60), helpful by 42% (25/60), and very helpful by 5% (3/60).
A number of other small changes were made over the course
of a year, and we found that completion rates for the first two
sessions increased from 69.5% (105/131) to 78% (70/89)
following implementation of all the changes.
Within a dynamic, monitored population, there are innumerable
approaches to improving engagement, and methods to do so
have been well described [1,5]. However, it is worth noting that
as reach is successful in subpopulations, each of these
subpopulations is likely to generate new issues of uptake,
engagement, and outcome.
Outcome
As with engagement, much has been written about how to
improve outcomes using many of the strategies already
discussed. The outcome optimization being discussed aligns
with movements toward outcome-based care and
measurement-based care [34], in which the delivery of
interventions provided to clinical populations should focus on
the use of outcomes to guide clinical decision making. We
briefly mentioned what constitutes a positive outcome (eg, a
clinically significant change) measured by loss of clinical status
or even abstinence from eating disorder behavior. However,
from a population-based prevalence reduction standpoint, there
are some important considerations, as illustrated by the eating
disorder program we are discussing. First, most of the studies
on new models to improve outcome focus on digital
interventions. Given some individuals’ preference for
face-to-face interventions, other treatment modalities and
methods should be considered—we mentioned teletherapy
above, for instance, as one obvious example. Second, as
mentioned previously, focusing on incremental improvements
in effect size may have less impact on prevalence than focusing
on increasing reach. Third, interventions should be selected and
designed with implementation in mind [5]. Mohr et al [33] noted
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that when digital interventions that are shown to be efficacious
in laboratory-based studies move to real-world settings,
individuals do not engage with the tools and implementation
often fails. Fourth, the complex issue of the ordering of
interventions needs to be considered in population-based models.
We, and others, have proposed stepped-care models as a
cost-effective approach and also as a way to identify
subpopulations that may need alternative approaches [14]. Thus,
randomized controlled trials remain an important component
of digital interventions. At the same time, our central thesis is
that researchers must consider issues related to dissemination
and implementation from the beginning [5]. This will lead to
interventions that maximize public health impact.
Refining the Public Health Model
The model overlaps with other public health models, such as
the highly influential Reach, Effectiveness, Adoption,
Implementation and Maintenance model [35]. Similar to other
public health models [36], we stressed the importance of offering
both prevention and intervention approaches to reduce the
prevalence. The model proposed here differs from existing
models in terms of focusing on the use of digital databases and
digital health interventions and innovations in reducing the
prevalence of targeted populations. These data and analytics
need to be monitored and interpreted by a multidisciplinary
team involved in program codesign and delivery so that the
digital health solution and its delivery can be quickly refined
and improved, an approach consistent with Mohr et al’s [5,17]
recommendation that program evaluation should be more rapid
and agile with iterative improvements. In the model we propose,
the key innovation is that the key outcomes (reach, uptake,
engagement, and outcome) are being simultaneously and
continuously monitored, with ongoing testing and refining of
strategies to improve these various indices. Fortunately, some
emerging studies deal with at least several components of our
proposed model. For instance, the Quit Sequential Multiple
Assignment Randomization Trial Utah trial uses a
cluster-randomized, multilevel sequential multiple assignment
randomized model to examine strategies to increase reach and
efficacy in community health centers [37].
System-Level Issues
Our proposed approach has focused on identifying the key
elements for reducing symptoms in individuals, to reduce the
prevalence of eating disorders in a population. However,
program delivery and access and uptake of interventions are
affected by a variety of system-level issues, including
regulations/policies (eg, reimbursement), service delivery (eg,
availability of trained providers), social environment (eg, support
of family/friends), infrastructure (eg, availability of exercise
equipment for those who may want to use it), accessibility (eg,
availability of reliable transportation), and, of course, funding
and reimbursement. For example, building out a teletherapy
option may be limited by professional practice guidelines and
issues of practicing across state lines, reimbursement, access to
privacy-protected systems, and/or professional attitudes and
training. The outcome optimization team needs to take these
factors into consideration so that possible strategies are
considered in the context of what can be achieved within the
system responsible for prevalence reduction. Another issue is
that there may be divergent agendas across different levels of
the organization. Providers, supervisors, division leaders, and
organizational leadership may have different ideas about what
a service should be doing or offering.
Another major challenge for the outcome optimization model
is for the outcome optimization team to have access to platforms
in which interventions can be easily offered and adapted for use
in various formats (eg, mobile apps and web browser access).
Furthermore, the delivery system needs to be integrated with a
broader health care delivery system. An example of a system
designed to integrate digital practice into a common health care
record is now being implemented in Australia [38]. Such a
system allows feedback between outcome optimization teams
and health care practitioners.
Putting It All Together: Prevalence
Reduction Through Outcome Optimization
Using this approach at the population level has the potential not
only to reduce population prevalence but also to provide
important information about intervention and prevention
mechanisms, subpopulation needs, and even how to provide
personalized and customized interventions to individuals in a
population. The model is based on data and data analyses, but
most importantly, on having an expert and technically proficient
team that is tasked with using data and novel trial designs to
conduct ongoing redesign, implementation, and rapid evaluation
of evolving interventions that adapt/provide for individuals’
needs and address the effects of interventions on all critical
variables (ie, from reach to outcome) that can potentially result
in greater overall reductions in prevalence. The creation of
outcome optimization teams within organizations tasked with
reducing prevalence would be the single most important step
toward optimizing outcomes.
Our approach also assumes that there is agreed-upon access to
users’ data and their willingness to provide information about
their progress. The use of such data will need to be transparent,
and the user will need to agree. Thorough and repeated efforts
will need to be made to ensure that such information follows
Health Insurance Portability and Accountability Act guidelines
and remains confidential. The concerns of individuals about
sharing data need to be taken seriously, and it is likely that many
will opt out of data sharing, given the many examples of how
personal data are being misused. However, there is also an
increasing movement—sometimes referred to as the quantified
self movement—toward health consumers having access to their
own data and making this information available to their health
providers and others to access.
Limitations of Dichotomous Measures as
Outcomes
Before discussing how an outcome optimization team model
might be enacted, it is important to note that prevalence rates
determined by caseness have a number of limitations.
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Psychopathology exists on a continuum, and individuals, over
time, may fall in and out of risk and/or caseness. Continuous
measures are much more likely to be informative than
categorical measures. However, for the foreseeable future,
prevalence reduction will be measured in terms of
reduction/prevention of caseness; thus, the reduction of
prevalence remains the most important goal of a
population-based approach.
More broadly, digital technologies will need to and are able to
address a number of other important issues besides any specific
psychopathology or risk that is being addressed. First,
dissemination and implementation research have tended to focus
on single disorders. However, nearly all mental health problems
presenting in practice have substantial comorbidities. In theory,
one could reduce the prevalence of one disorder in an individual
while having little effect on several other important problems.
A number of studies are examining transdiagnostic approaches
and considering outcomes across multiple categories and
dimensions [12]. Second, being a case may be less important
to the individual identified as such than other issues, such as
quality of life and well-being. The inclusion of variables relevant
to the individual should be part of an intervention system. Third,
health behaviors and risk factors (eg, obesity) are intrinsically
related to many disorders and should also be addressed.
Unfortunately, few models of multicomponent, multidimensional
interventions assessed over time have been reported. Fourth,
individual-level data obtained through ecological momentary
assessment and other techniques can be used as part of a
population reduction strategy, and an outcome optimization
team will need to consider both general and personalized
interventions as part of an array of opportunities provided to
individuals at risk for or with clinical disorders. The model we
describe is applicable to multidimensional personalized
interventions once models for doing so have been developed.
A Note on Prevention
A major strength of digital technology and the use of an outcome
optimization team is that screenings and other methods can be
used to identify both individuals at risk for and/or with clinical
disorders [39] and to address issues of reach, uptake, use, and
outcome in at-risk populations using the methods discussed
earlier. In most settings, we know of where screenings are used
that could identify both risk and caseness; only the latter group
is addressed. Not providing preventive interventions is a lost
opportunity. We realize that there are many issues with doing
so: the burden of adding prevention onto the responsibilities of
clinical services, the challenge of providing prevention at a low
cost given the large number of individuals who might need to
be provided with interventions, and issues of reimbursement,
to name a few. However, scalable interventions shown to reduce
onset for common problems such as depression [39] and eating
disorders [20] are available. Implementing, altering, and
adapting them to optimize reach, uptake, use, and outcome
(reduction in risk) using the methods we have described may
be one of the most important challenges we face.
How Reduction of Population-Wide
Prevalence Could Happen
Efforts to reduce the population-wide prevalence of disorders
will require considerable resources, and any effort to achieve
such reductions will need to be aligned with
government/institutional/provider/community perspectives
and/or other values and goals. There are many health care
systems (eg, Kaiser Permanente, the United States Department
of Veteran Affairs) that consider prevalence reduction of
disorders (eg, suicide, posttraumatic stress disorder [PTSD],
and depression) within their populations to be of importance
and routinely screen their populations for problems such as
depression and PTSD. Reducing prevalence across populations
is similarly critical to many governments and other institutions
with missions to serve specific groups. For example, colleges
and universities have a strong interest in reducing the prevalence
of mental health disorders and ultimately reducing the number
of individuals who drop out from college with the result that
many could create outcome optimization teams focused on
reducing these outcomes in their populations. Another option
in health care systems is that groups of collaborative care teams
could take responsibility for the outcome optimization of
preventive and clinical interventions in their panels, sharing
findings among the teams. However, deploying digital
technologies focused on reach and uptake may create a major
problem for the provider systems: it is likely to create a major
increase in demand for services. As we go forward,
considerations of the cost-effectiveness and creative design of
service delivery models, including stepped-care approaches,
will need to be layered into the models.
A population-wide prevalence reduction program also has
implications for the health care system, where cost/benefits and
trade-offs of combined prevention and intervention need to be
considered and may complete competing interests, where, for
instance, might be more interested in the short-term benefits of
treating cases rather than preventing new cases and considering
needs to be given to who directs the outcome optimization team
goals.
An alternative approach to a total population-based approach
is to focus first on outcome optimization within defined
segments of the total population, for instance, individuals
identified through screening. This approach does not focus on
reductions in overall prevalence but only the reduction of risk
and caseness within a subset of the entire population of interest.
Working with the National Eating Disorders Association, we
created a virtual outcome optimization team (comprising
information scientists, statisticians, data managers,
psychologists, psychiatrists, program designers, software
providers, and others) to focus on both prevention and
intervention for eating disorders for individuals identified
through the National Eating Disorders Association screening
tool. As an example of the need to enact new models of care
delivery, over a 6-month period, 71,362 individuals completed
the screening and most individuals (61,585/71,362, 86.30%)
screened positive for an eating disorder. In addition, 10.20%
(6602/71,362) were screened as being at high risk for the
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development of an eating disorder. Of those who screened
positive for an eating disorder, 85.90% (52,902/61,585) had
never received treatment and only 3.00% (1847/61,585) were
currently in treatment [40].
As another step forward, funding agencies should actively
support innovative population-based interventions that use newer
designs, including just-in-time adaptive interventions and other
ways of thinking about and using digital technology and data
to improve outcomes. As noted previously, we remain advocates
of traditional randomized controlled trials, when implemented
following intervention optimization, and we see them as being
most meaningful when instituted within populations where they
might eventually be deployed. Funding agencies might initially
focus not on a comprehensive population prevalence reduction
model but initially examine issues that would be relevant to the
model. The investigators would be required to focus on defined,
large populations, reach, uptake, engagement, and outcomes
using modern data analytics and methods—and many such
studies are now underway—with a demonstration as to how,
where, and when they would be implemented in real-world
situations.
Implementing prevalence reduction in populations is a challenge,
but given the large number of people in any population at risk
for or with a clinical disorder, scalable, innovative models of
service delivery are urgently required [16]. Digital technologies
can enable scalability, but new systems and models need to be
developed to take advantage of this capability. We have argued
that the implementation of outcome optimization teams
represents an important possible approach to enable the delivery
of technology-facilitated mental health interventions in a way
that can optimize outcomes for the entire population.
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